Atlas Trials

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

Clinical trial NCT01772368 · COMPLETED

Trial details

NCT number
NCT01772368
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2013-01-01
Primary completion
2013-06-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.